Activity of matrix metalloproteinases-2 and -9 in advanced laryngeal cancer

Otolaryngology - Head and Neck Surgery

Volumn 128, Issue 1, 2003, Pages 132-136

  Bogusiewicz, Michal ^a   Stryjecka Zimmer, Marta ^a   Szymanski, Marcin ^a   Rechberger, Tomasz ^a   Golabek, Wieslaw ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; PROTEINASE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; LARYNX CANCER; LYMPH NODE METASTASIS; METASTASIS; PATHOPHYSIOLOGY; ZYMOGRAPHY;

EID: 0037285253     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhn.2003.8     Document Type: Article

References (19)

1. Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998;10:602-8.
2. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274:21491-4.
3. McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 2000;6:149-56.
4. Westermarck J, Kahari V-M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999;13:781-92.
5. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996;3:895-904.
6. Magary SP, Ryan MW, Tarnuzzer RM, et al. and tissue inhibitor of metalloproteinases in laryngeal and squamous cell carcinoma: a quantitative study. Otol Head Neck Surg 2000;122:712-26.
7. Cazarola M, Hernandez L, Nadal A, et al. Collagenae-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol 1998;186:144-50.
8. Tokumaru Y, Fujii M, Otani Y, et al. Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: studies of clinical samples and in vitro cell lines co-cultured with fibroblasts. Cancer Lett 2000;150:15-21.
9. Sobin LH, Wittekind C. International Union Against Cancer (UICC) TNM Classification of Malignant Tumours. 5th ed. New York (NY): Wiley; 1997. p. 17-50.
10. Larynx. In: American Joint Committee on Cancer: AJCC Cancer Staging Manual. 5th ed. Philadelphia (PA): Lippincott-Raven Publishers; 1997. p. 41-46.
11. Woessner JF Jr. Quantification of matrix metalloproteinases in tissue samples. Methods Enzymol 1995;248:510-28.
12. Cadman E, Bastwick IB, Eichberg I. Determination of protein by a modified Lowry procedure in the presence of commonly used detergents. Anal Biochem 1979;96:21-3.
13. Hibbs MS, Hasty KA, Seyer JM, et al. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 1985;260:2493-500.
14. Hidalgo M, Eckhardt SG. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 2001;93:178-93.
15. Fielding J, Scholefield J, Stuart P, et al. A randomized double-blind placebo controlled study of Marimastat in patients with inoperable gastric adenocarcinoma. Proc Am Soc Clin Oncol 1996;19:240.
16. Imanishi Y, Fujii M, Tokumaru Y, et al. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum Pathol 2000;31:895-904.
17. Miyajima Y, Nakano R, Morimatsu M. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma. Ann Otol Rhinol Laryngol 1995;104:678-84.
18. Kusukawa J, Saguri Y, Shima I, et al. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. Am J Clin Pathol 1993;99:18-23.
19. Weeks JG, Halme J, Woessner JF Jr. Extraction of collagenase from the involuting rat uterus. Biochim Biophys Acta 1976;445:205-14.